BioCentury
ARTICLE | Financial News

AB2 Bio completes venture financing

January 18, 2016 8:00 AM UTC

AB2 Bio Ltd., Lausanne, Switzerland Business: Inflammation Date completed: 2016-01-11 Type: Venture financing Raised: CHF21 million ($21.1 million) Investors: Existing investors; new investors ...